Patents by Inventor Scott D. Meier

Scott D. Meier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified nucleotides methods and kits
    Patent number: 10526652
    Abstract: Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: January 7, 2020
    Assignee: Pierce Biotechnology, Inc.
    Inventors: Christopher L. Etienne, Kay K. Opperman, Barbara J. Kaboord, Scott D. Meier, Jean-Samuel Schultz
  • MODIFIED NUCLEOTIDES METHODS AND KITS
    Publication number: 20180127822
    Abstract: Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.
    Type: Application
    Filed: October 25, 2017
    Publication date: May 10, 2018
    Applicant: Pierce Biotechnology, Inc.
    Inventors: Christopher L. Etienne, Kay K. Opperman, Barbara J. Kaboord, Scott D. Meier, Jean-Samuel Schultz
  • Modified nucleotides methods and kits
    Patent number: 9828633
    Abstract: Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: November 28, 2017
    Assignee: Pierce Biotechnology, Inc.
    Inventors: Christopher L. Etienne, Kay K. Opperman, Barbara J. Kaboord, Scott D. Meier, Jean-Samuel Schultz